Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II)

被引:13
作者
Prabhakar, G
Mehra, KS
Ramamoorthy, N
Chattopadhyay, S
Oommen, R
Narasimhan, S
Nair, NA
Gunasekaran, S
机构
[1] Board Radiat & Isotope Technol, Radiopharmaceut Programme, Navi Mumbai 400705, India
[2] Christian Med Coll & Hosp, Vellore 632004, Tamil Nadu, India
关键词
D O I
10.1016/S0969-8043(98)00168-7
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
A reliable method of labelling MIBG with I-131 is reported. Radioiodination involved nucleophilic exchange reaction (160 degrees C, 30 min) catalysed by directly added Cu(II) or by Cu(I) generated in situ by addition of Na2S2O5 to CuSO4. An additional step of purification of the radiolabelled MIBG by anion exchange chromatography is recommended, The radiochemical (RC) yield was over 90%, while the typical RC purity of I-131-MIBG was not less than 98%. Higher labelling yield was achieved with Cu(I) than when using Cu(II), and with I-125 (commercial product) than with 131I obtained by wet radiochemical processing method in-house. The purity and stability of MIBG-I-131 was confirmed by biodistribution studies in monkeys with 0.03% and 0.8% uptake in adrenals and myocardium, respectively. It is concluded that Cu(I) or Cu(II) catalysed radioiodination method is well suited for production of MIBG-I-131. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1011 / 1014
页数:4
相关论文
共 14 条
[1]  
BEIERWALTES WH, 1987, NUCL MED BIOL, V14, P183
[2]  
CHATTOPADHYAY S, 1994, IND J NUCL MED, V9, P67
[3]   KIT TYPE LABELING OF [I-123] METAIODOBENZYLGUANIDINE [J].
DOUGAN, H ;
LYSTER, DM ;
VINCENT, JS ;
RIHELA, T .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (05) :531-544
[4]   SOLID-PHASE EXCHANGE RADIOIODINATION OF ARYL IODIDES - FACILITATION BY AMMONIUM-SULFATE [J].
MANGNER, TJ ;
WU, JL ;
WIELAND, DM .
JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (08) :1484-1488
[5]  
MERTENS J, 1987, EUR J NUCL MED, V13, P380, DOI 10.1007/BF00253000
[6]  
Mertens J, 2005, P IAEA CN 130 INT S, P101
[7]  
MERTENS J, 1985, RADIOPHARMACEUTICALS, P303
[8]  
MURUGESAN S, 1992, IND J NUCL MED, V7, P7
[9]  
NEVES M, 1992, APPL RADIAT ISOTOPES, V43, P737
[10]  
OOMMEN R, 1996, INTERNAL REPORT CMC